文献速递肾移植

肾移植虚拟交叉配型检测的原理

Principles of Virtual Crossmatch Testing for Kidney Transplantation.
PubMed 文献 · Kidney Int Rep · 2022-03-15

本文综述了虚拟交叉配型(VXM)的原理:通过分析受者抗HLA抗体与供者HLA分型两项独立实验室检测结果评估免疫相容性,替代需混合血清与供者细胞的物理交叉配型。基于VXM的方法可统计学显著缩短冷缺血时间且不增加超急性排斥反应,但VXM目标(预测物理交叉配型结果还是移植后结局)尚无共识。

要点

  • VXM通过受者抗HLA抗体和供者HLA分型两项独立检测评估免疫相容性。
  • 基于VXM的方法可统计学显著缩短冷缺血时间,不增加超急性排斥反应。
  • VXM适用于致敏与非致敏患者,其应用取决于移植中心对免疫风险的耐受度。

核心结论

  • VXM通过分析受者抗HLA抗体与供者HLA分型评估免疫相容性,虽面临挑战,未来预计将更常使用,取决于移植中心对免疫风险的耐受度。

研究设计与样本

  • 综述,阐述虚拟交叉配型(VXM)的原理、与物理交叉配型(PXM)的区别及临床应用场景。

主要发现

  • 物理交叉配型如补体依赖细胞毒性交叉配型(CDCXM)和流式细胞术交叉配型(FCXM)需混合患者血清与供者细胞,劳动强度大且后勤困难。
  • VXM通过分析受者抗HLA抗体和供者HLA分型两项独立实验室检测结果评估免疫相容性。
  • VXM的目标是移植前风险分层,但对风险分层是预测物理交叉配型结果还是移植后结局尚无共识。
  • 固相法检测抗HLA抗体及基于DNA的高分辨率供者HLA分型使VXM常规应用成为现实。
  • 基于VXM的方法使冷缺血时间统计学显著缩短,且不增加超急性排斥反应。

临床怎么用

  • VXM可应用于致敏和非致敏患者的不同场景。
  • VXM的常规使用取决于移植中心对免疫风险的耐受度。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Human leukocyte antigens (HLAs) are the primary determinants of alloimmunity. A crossmatch test is a test that determines the immunologic risk of a recipient with a potential donor by ensuring that there are no transplant-relevant circulating antibodies in the recipient directed against donor antigens. Physical crossmatch (PXM) tests, such as complement-dependent cytotoxicity crossmatch (CDCXM) and flow cytometry crossmatch (FCXM), require mixing of patient serum and donor cells, are labor intensive, and are logistically challenging. Virtual crossmatch (VXM) test assesses immunologic compatibility between recipient and potential donor by analyzing the results of 2 independently done physical laboratory tests-patient anti-HLA antibody and donor HLA typing. The goal of VXM is pretransplant risk stratification-though there is no consensus on whether such risk assessment involves predicting the PXM result or the posttransplant outcome. Although the concept of VXM is not new, the advent of solid-phase assays for detecting circulating antibodies in the recipient directed against individual HLA and DNA-based methods for typing donor HLA specificities at a higher resolution makes the routine use of VXM a reality. Accordingly, VXM may be applied at different scenarios-both for sensitized and nonsensitized patients. Implementation of VXM-based approach has resulted in statistically significant reduction in cold ischemia time without an increase in hyperacute rejection episodes. Though there are considerable challenges, VXM is expected to be used more often in the future, depending on the transplant center's tolerance of immunologic risk.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Bhaskaran MC, Heidt S, Muthukumar T, et al. Principles of Virtual Crossmatch Testing for Kidney Transplantation. Kidney Int Rep. 2022. PMID: 35685330. doi:10.1016/j.ekir.2022.03.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。